Skip to main content
Caplight Logo









Cure

Cure

Private
BerlinHealthcare & Life Scienceshttps://www.getcure.app/

Last Round

Series A

Sep 15, 2022

Total Funding Raised

$19.6M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Cure is a digital health company that provides an AI-driven platform for the on-demand delivery of medications and telehealth services.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Last-Mile Delivery, Telemedicine

Business Model

B2B2C

Customer Profile

Marketplace Commission, Usage-Based SaaS

AI Layer

Application

Keywords

pharmacy deliveryon-demand deliverydigital pharmacye-pharmacylast-mile deliverytelemedicineorder management platformretail technologyquick commerceq-commerceprescription deliverymarketplace platformB2B2CAI co-pilot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cure Comparables

Compare Cure with similar companies based on industry and business-model similarity.

Cure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pharmao
78%
Joom
77%
Delivery Hero
73%

Cure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 15, 2022
SeedJan 1, 2022

Key People

Founding team and executive leadership

Ali El-Ali

CEO Co-Founder

Founding Team

Cure Investors

Notable investors and investment history

Cure investors
InvestorRounds
J12 VenturesSeed, Series A
J VenturesSeed, Series A
Craft VenturesSeed, Series A
BreegaSeries A
Pi LabsSeries A
Abstract VenturesSeed, Series A
Abstract VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Open roles increased to 21, 95% of current headcount.

  • Aug 22, 2026

    Monthly visitors increased 58% MoM.

Cure Filings

Explore SEC and related filing metadata, where available.

Cure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cure's valuation, stock price, and market status.

Is Cure a public or private company?

Cure is a private company.

What is the current stock price of Cure?

Cure is a private company with no public stock price. No recent secondary market data is available.

How much is Cure worth (valuation)?

Valuation information for Cure is not publicly available.

Can I buy Cure stock?

Cure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cure's last funding round?

Cure's most recent funding round was Series A on September 15, 2022.

Who are the main investors in Cure?

Key investors in Cure include Breega.

Will Cure IPO soon?

No public IPO plans have been announced for Cure.

How can I track Cure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range22
Year Founded2021
Last FundingSep 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?